Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000209:etiology; D006328:Cardiac Catheterization; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000628:therapy*; D024741:Cardiomyopathy, Hypertrophic, Familial / Q000150:complications / Q000628:therapy; D004417:Dyspnea / Q000209:etiology; D000431:Ethanol / Q000627:therapeutic use*; D017079:Exercise Tolerance; D005260:Female; D006333:Heart Failure / Q000209:etiology; D006346:Heart Septum / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy; D012737:Sex Factors; D016896:Treatment Outcome; D014694:Ventricular Outflow Obstruction / Q000209:etiology
D012597:Sclerosing Solutions; D000431:Ethanol